翻訳と辞書
Words near each other
・ Neuromuscular therapy
・ Neuromuscular ultrasound
・ Neuromuscular-blocking drug
・ Neuromyelitis optica
・ Neuromyotonia
・ Neuron
・ Neuron (disambiguation)
・ Neuron (journal)
・ Neuron (software)
・ Neuron Data
・ Neuron doctrine
・ Neuron Robotics
・ Neuron-derived orphan receptor 1
・ Neuronal calcium sensor
・ Neuronal calcium sensor-1
Neuronal ceroid lipofuscinosis
・ Neuronal encoding of sound
・ Neuronal galvanotropism
・ Neuronal lineage marker
・ Neuronal memory allocation
・ Neuronal migration disorder
・ Neuronal noise
・ Neuronal process
・ Neuronal recycling hypothesis
・ Neuronal self-avoidance
・ Neuronal tiling
・ Neuronal tracing
・ Neuronal tuning
・ NeuroNames
・ Neuronavigation


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Neuronal ceroid lipofuscinosis : ウィキペディア英語版
Neuronal ceroid lipofuscinosis

Neuronal ceroid lipofuscinoses (NCL) is the general name for a family of at least eight genetically separate neurodegenerative disorders that result from excessive accumulation of lipopigments (lipofuscin) in the body's tissues. These lipopigments are made up of fats and proteins. Their name comes from the word stem ''lipo-'', which is a variation on "lipid" or "fat", and from the term ''pigment'', used because the substances take on a greenish-yellow color when viewed under an ultraviolet light microscope. These lipofuscin materials build up in neuronal cells and many organs, including the liver, spleen, myocardium, and kidneys.
==General characteristics==
The classic characterization of the group of neurodegenerative, lysosomal storage disorders called the neuronal ceroid lipofuscinoses (NCLs) is through the progressive, permanent loss of motor and psychological ability with a severe intracellular accumulation of lipofuscins, with the United States and northern European populations having slightly higher frequency with an occurrence of 1 in 10,000. There are four classic diagnoses that have received the most attention from researchers and the medical field, differentiated from one another by age of symptomatic onset, duration, early-onset manifestations such as blindness or seizures, and the forms which lipofuscin accumulation takes.〔
In the early infantile variant of NCL (also called INCL or Santavuori-Haltia), probands appear normal at birth, but early visual loss leading to complete retinal blindness by the age of 2 years is the first indicator of the disease; by 3 years of age a vegetative state is reached and by 4 years isoelectric encephalograms confirm brain death. Late infantile variant usually manifests between 2 and 4 years of age with seizures and deterioration of vision. The maximum age before death for late infantile variant is 10–12 years. Juvenile NCL (JNCL, Batten Disease, or Spielmeyer-Vogt), with a prevalence of 1 in 100,000, usually arises between 4 and 10 years of age; the first symptoms include considerable vision loss due to retinal dystrophy, with seizures, psychological degeneration, and eventual death in the mid- to late-20s or 30s ensuing. Adult variant NCL (ANCL or Kuf’s Disease) is less understood and generally manifests milder symptoms; however, while symptoms typically appear around 30 years of age, death usually occurs ten years later.
All the mutations that have been associated with this disease have been linked to genes involved with the neural synapses metabolism – most commonly with the reuse of vesicle proteins.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Neuronal ceroid lipofuscinosis」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.